Skip to main content
. 2020 Sep 11;3(1):101–108. doi: 10.1016/j.cjco.2020.09.005

Figure 2.

Figure 2

Impact of ranolazine vs placebo on angina equivalents in patients with coronary microvascular dysfunction: (A) angina frequency; (B) physical functioning; (C) angina stability; (D) treatment satisfaction; and (E) quality of life. CI, confidence interval; IV, weighted mean difference; SE, standard error; SD, standard deviation.